Vosevi effective rescue therapy in patients with chronic HCV after DAA treatment failure

WASHINGTON — Vosevi, a triple-combination therapy for chronic hepatitis C virus infection, was effective when used as a rescue treatment in patients who did not achieve sustained virologic response with direct-acting antiviral agents.“Despite a high efficacy in overall safety of the DAAs, still about 2% of patients fail to achieve SVR,” Christiana Graf, MD, of Goethe University Hospital in Frankfurt, Germany, told attendees at The Liver Meeting. “Those patients need an alternative treatment option, and according to the international guidelines for AASLD as well asRead More

Generated by Feedzy